| Product Code: ETC6365781 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Belgium continues to rely on key exporters such as the USA, Austria, Netherlands, Hungary, and the UK for its therapeutic vaccines import shipments in 2024. Despite a high concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market is experiencing impressive growth with a compound annual growth rate (CAGR) of 39.8% from 2020 to 2024. However, there was a notable decline in the growth rate from 2023 to 2024 at -59.2%, suggesting potential shifts or challenges in the market dynamics for therapeutic vaccines imports in Belgium.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Therapeutic Vaccines Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Belgium Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Belgium Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Belgium Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 Belgium Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Belgium |
4.2.3 Rising awareness about preventive healthcare measures in the population |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for vaccine development and approval |
4.3.2 High costs associated with vaccine research, development, and production |
4.3.3 Limited availability of skilled healthcare professionals for administering therapeutic vaccines |
5 Belgium Therapeutic Vaccines Market Trends |
6 Belgium Therapeutic Vaccines Market, By Types |
6.1 Belgium Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Belgium Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 Belgium Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 Belgium Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 Belgium Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Belgium Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 Belgium Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 Belgium Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 Belgium Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 Belgium Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Belgium Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Belgium Therapeutic Vaccines Market Export to Major Countries |
7.2 Belgium Therapeutic Vaccines Market Imports from Major Countries |
8 Belgium Therapeutic Vaccines Market Key Performance Indicators |
8.1 Number of clinical trials for therapeutic vaccines conducted in Belgium |
8.2 Rate of adoption of therapeutic vaccines in the healthcare system |
8.3 Percentage of healthcare budget allocated to preventive healthcare measures |
8.4 Average time taken for regulatory approval of therapeutic vaccines in Belgium |
8.5 Number of partnerships between pharmaceutical companies and research institutions for vaccine development. |
9 Belgium Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Belgium Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Belgium Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 Belgium Therapeutic Vaccines Market - Competitive Landscape |
10.1 Belgium Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Belgium Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |